Status:
COMPLETED
Repeated-dose Behavioral Intervention to Reduce Opioid Overdose
Lead Sponsor:
San Francisco Department of Public Health
Conditions:
Opioid-Related Disorders
Drug Overdose
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
REBOOT is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among naloxone recipients with opioid use disorder. It includes an established overdose educati...
Eligibility Criteria
Inclusion
- Age 18-65 years
- Characteristics of opioid use history
- Previously received take-home naloxone
- No life-threatening illness likely to progress clinically during trial
- Able/willing to provide informed consent and locator information, communicate in English, and adhere to visit schedule
Exclusion
- Suicidal ideation
- Participating in another interventional study that could possibly impact the study's outcomes of interest
- Planning to leave San Francisco/Boston metro area during study
- Previously exposed to REBOOT counseling intervention
- Any condition that, in the Principal Investigator's judgment, interferes with safe study participation or adherence to study procedures
Key Trial Info
Start Date :
April 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2023
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT03838510
Start Date
April 22 2019
End Date
December 12 2023
Last Update
June 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco Department of Public Health
San Francisco, California, United States, 94102
2
Boston Medical Center
Boston, Massachusetts, United States, 02118